在与急性髓性白血病的战斗中:生物学,突破和希望
Jiayang Bao1,2, Oliver Freund1,2, Logan Sund1,2
1Division of Hematology and Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15232, USA.
Cells
|February 26, 2026
概括
急性髓性白血病 (AML) 是一种复杂的血液癌症,由遗传变化和异常细胞发育驱动. 了解它的生物学是开发这种侵袭性疾病的新治疗方法的关键.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性髓性白血病 (AML) 是一种异质和侵略性的癌症,其特征是不成熟的髓性细胞过度生长.
- 这会导致骨髓衰竭,低血细胞计数,以及感染和出血等严重并发症.
- 治疗耐药性和疾病复发是由遗传多样性和持久性白血病干细胞驱动的.
研究的目的:
- 为了解AML病理生物学提供一个全面的框架.
- 整合有关染色体异常,基因调节和骨髓微环境的知识.
- 以突出先进的分析方法来推进AML研究.
主要方法:
- 对AML病理生物学现有文献的综述.
- 从染色体异常,转录和表观遗传网络中整合数据.
- 重点是新兴技术,如多omics,单细胞和空间分析.
主要成果:
- AML是由受遗传突变,表观遗传变化和改变信号的驱动而引起的血液形成中断引起的.
- 白血病干细胞 (LSCs) 有助于治疗耐药性和复发.
- 骨髓微环境在AML进展中起着至关重要的作用.
结论:
- 对AML的整体理解需要整合遗传,表观遗传和微环境因素.
- 像多组学和单细胞分析这样的先进技术对于剖析AML复杂性至关重要.
- 这些方法加速了针对AML的针对性,基于机制的治疗方法的开发.
更多相关视频
06:28Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
Published on: November 10, 2023
4.3K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.8K
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Bone Marrow Sampling and Transplants
1.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Disorders of Leukocytes
2.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.1K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
